Cargando…

Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases

Detalles Bibliográficos
Autores principales: Goulenok, Tiphaine, Delaval, Laure, Delory, Nicole, François, Chrystelle, Papo, Thomas, Descamps, Diane, Ferré, Valentine Marie, Sacré, Karim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000912/
https://www.ncbi.nlm.nih.gov/pubmed/35434653
http://dx.doi.org/10.1016/S2665-9913(22)00099-6
_version_ 1784685552949264384
author Goulenok, Tiphaine
Delaval, Laure
Delory, Nicole
François, Chrystelle
Papo, Thomas
Descamps, Diane
Ferré, Valentine Marie
Sacré, Karim
author_facet Goulenok, Tiphaine
Delaval, Laure
Delory, Nicole
François, Chrystelle
Papo, Thomas
Descamps, Diane
Ferré, Valentine Marie
Sacré, Karim
author_sort Goulenok, Tiphaine
collection PubMed
description
format Online
Article
Text
id pubmed-9000912
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-90009122022-04-12 Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases Goulenok, Tiphaine Delaval, Laure Delory, Nicole François, Chrystelle Papo, Thomas Descamps, Diane Ferré, Valentine Marie Sacré, Karim Lancet Rheumatol Comment Elsevier Ltd. 2022-07 2022-04-11 /pmc/articles/PMC9000912/ /pubmed/35434653 http://dx.doi.org/10.1016/S2665-9913(22)00099-6 Text en © 2022 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Comment
Goulenok, Tiphaine
Delaval, Laure
Delory, Nicole
François, Chrystelle
Papo, Thomas
Descamps, Diane
Ferré, Valentine Marie
Sacré, Karim
Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases
title Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases
title_full Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases
title_fullStr Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases
title_full_unstemmed Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases
title_short Pre-exposure anti-SARS-CoV-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases
title_sort pre-exposure anti-sars-cov-2 monoclonal antibodies in severely immunocompromised patients with immune-mediated inflammatory diseases
topic Comment
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000912/
https://www.ncbi.nlm.nih.gov/pubmed/35434653
http://dx.doi.org/10.1016/S2665-9913(22)00099-6
work_keys_str_mv AT goulenoktiphaine preexposureantisarscov2monoclonalantibodiesinseverelyimmunocompromisedpatientswithimmunemediatedinflammatorydiseases
AT delavallaure preexposureantisarscov2monoclonalantibodiesinseverelyimmunocompromisedpatientswithimmunemediatedinflammatorydiseases
AT delorynicole preexposureantisarscov2monoclonalantibodiesinseverelyimmunocompromisedpatientswithimmunemediatedinflammatorydiseases
AT francoischrystelle preexposureantisarscov2monoclonalantibodiesinseverelyimmunocompromisedpatientswithimmunemediatedinflammatorydiseases
AT papothomas preexposureantisarscov2monoclonalantibodiesinseverelyimmunocompromisedpatientswithimmunemediatedinflammatorydiseases
AT descampsdiane preexposureantisarscov2monoclonalantibodiesinseverelyimmunocompromisedpatientswithimmunemediatedinflammatorydiseases
AT ferrevalentinemarie preexposureantisarscov2monoclonalantibodiesinseverelyimmunocompromisedpatientswithimmunemediatedinflammatorydiseases
AT sacrekarim preexposureantisarscov2monoclonalantibodiesinseverelyimmunocompromisedpatientswithimmunemediatedinflammatorydiseases